Showing results (1981-1990 of 2,175) with videos related to

Sort By:
Pageof 218
European Journal of Heart Failure|May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trialAdriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of Cardiac Failure|July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) TrialRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.
American Journal of Ophthalmology|October 10, 2017
Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy With Swept-Source Optical Coherence TomographyJay C Wang, Inês Laíns, Joana Providência, et al.
American Heart Journal|June 19, 2018
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarctionJennifer A Rymer, Michael W Tempelhof, Robert M Clare, et al.
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Circulation|May 16, 2007
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyKaren P Alexander, L Kristin Newby, Christopher P Cannon, et al.
JACC. Heart Failure|March 14, 2014
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomesMaria Cecilia Bahit, Renato D Lopes, Robert M Clare, et al.
Dermatology Online Journal|July 29, 2026
The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panelLauren DeBusk, Brooke Bartley, April W Armstrong, et al.
Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.
Pageof 218